Cinical Trial

Truvada & Miraviroc for Long COVID

This trial will test if two repurposed HIV antivirals can reduce symptom burden in adult participants with Long COVID.

Is this a virtual opportunity?
No, this is not a virtual opportunity.

What are the location requirements?
You must be located in the USA.

Will there be in-person visits? If so, how many?
Yes, there will be 6 in-person visits.

What is the length of participation?
The length of participation is 180 days.

What health qualifications are there to participate?
Long COVID (required proof of COVID infection which caused Long COVID)

What kinds of tasks are associated with participation?
There will be blood draws, saliva collection, an EndoPat test, as well as surveys.

You may inquire by filling out the form below, or emailing CoreResearch@mountsinai.org or calling (212) 241-8454. Thank you for your interest.

Previous
Previous

Sana Device for Post-Treatment Lyme disease and Chronic Pain

Next
Next

Humanity Neurotech Device for Long COVID Cognitive Dysfunction